PDS Biotechnology Reports Q3 2026 Net Loss of $7.6 Million

PDS Biotechnology reported a net loss of $7.6 million, or $0.11 per share, for the third quarter of 2026, compared with a $9.0 million loss a year earlier. Cash and cash equivalents totaled $15.2 million at September 30, 2026. The company also reported progress in its PDS0301 program and an initial…